Eisai CoESAIY +0.34%66 Pretax Margin % is -3.86% as of Mar. 2026. GuruFocus rates ESAIY with a GF Score™ of 66/100 and a GF Value™ of $8.73 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 955 Drug Manufacturers companies, Eisai Co ranks worse than 52.77% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Eisai Co's Pre-Tax Income for the
three
months ended in Mar. 2026 was $-50 Mil. Eisai Co's Revenue for the
three
months ended in Mar. 2026 was $1,295 Mil. Therefore, Eisai Co's pretax margin for the quarter that ended in Mar. 2026 was -3.86%.
The historical rank and industry rank for Eisai Co's Pretax Margin % or its related term are showing as below:
ESAIY'
s Pretax Margin % Range Over the Past 10 Years
Min: 6.05 Med: 8.22 Max: 18.41
Current: 6.18
ESAIY's Pretax Margin % is ranked worse than 52.77% of 955
companies
in the Drug Manufacturers industry
Industry Median: 7.28
vs ESAIY: 6.18
Eisai Co (OTCPK:ESAIY) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Eisai Co Pretax Margin % Related Terms
Eisai Co Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Eisai Co's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Eisai Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eisai Co Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Eisai Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Eisai Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eisai Co (ESAIY) has a Pretax Margin % of -3.86% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Eisai Co and its competitors. Over the past decade, Eisai Co's Pretax Margin % has ranged from 6.05 to 18.41. According to the industry distribution chart, Eisai Co ranks #504 out of 955 companies in the Drug Manufacturers industry, placing it in the top 52.8%.
Is Eisai Co's Pretax Margin % too high?
Eisai Co's current Pretax Margin % is -3.86%. Over the past 10 years, this metric has ranged from a low of 6.05 to a high of 18.41. Based on the distribution chart, Eisai Co ranks #504 out of 955 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Eisai Co has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eisai Co's Pretax Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Eisai Co ranks #504 out of 955 companies for Pretax Margin %. This places Eisai Co in the lower half of its industry. The industry median Pretax Margin % is 7.28. Historically, Eisai Co's own Pretax Margin % has ranged from 6.05 to 18.41 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.28, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Eisai Co and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eisai Co's current Pretax Margin % is -3.86%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eisai Co stock overvalued right now?
Based on GuruFocus' analysis, Eisai Co (ESAIY) is currently considered Significantly Undervalued. The stock's GF Value™ is $8.73, compared to a current price of $5.98 — trading 31.5% below its estimated fair value. The current Pretax Margin % is -3.86%. Eisai Co's overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Eisai Co (ESAIY), the current Pretax Margin % is -3.86% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eisai Co (ESAIY) Overvalued in 2026?
Based on GuruFocus' analysis, Eisai Co stock appears to be undervalued.
The current stock price of $5.98 is trading 31.5% below its estimated GF Value™ of $8.73.
GuruFocus considers Eisai Co to be Significantly Undervalued.
Key valuation signals for ESAIY:
Pretax Margin %: -3.86%
GF Value™: $8.73 vs. price of $5.98 (31.5% below fair value)
No single metric tells the full story. See the ESAIY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of research and development, manufacturing, sales, import, and export of pharmaceuticals. The pharmaceutical business is categorized by region, including East Asia & Global South; Europe, Middle East, Africa, Russia, Oceania (EMEA); Americas; China; and Japan. The company also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived from its American pharmaceutical business, followed by its Japanese pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.
66GF Score
Get the complete analysis for ESAIY
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ESAIY has been successfully added to your 
